Gaboxadol
- Generic Name
- Gaboxadol
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C6H8N2O2
- CAS Number
- 64603-91-4
- Unique Ingredient Identifier
- K1M5RVL18S
- Background
Gaboxadol also known as 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP) is an experimental sleep aid drug developed by Lundbeck and Merck, who reported increased deep sleep without the reinforcing effects of benzodiazepines. Development of Gaboxadol was stopped in March 2007 after concerns regarding safety and efficacy. It acts on the GABA system, but in a seemingly different way from benzodiazepines and other sedatives.
- Indication
Investigated for use/treatment in sleep disorders and insomnia.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath